Optimal Clinical Doses of Faropenem, Linezolid, and Moxifloxacin in Children With Disseminated Tuberculosis: Goldilocks.
about
A Combination Regimen Design Program Based on Pharmacodynamic Target Setting for Childhood Tuberculosis: Design Rules for the Playground.Concentration-Dependent Synergy and Antagonism of Linezolid and Moxifloxacin in the Treatment of Childhood Tuberculosis: The Dynamic Duo.Harnessing Novel Quantitative Pharmacology Approaches to Optimize the Treatment of Children With Tuberculosis.Linezolid for Infants and Toddlers With Disseminated Tuberculosis: First Steps.Partnerships to Design Novel Regimens to Treat Childhood Tuberculosis, Sui Generis: The Road Ahead.The paradigm shift to end tuberculosis. Are we ready to assume the changes?Current therapies for the treatment of multidrug-resistant tuberculosis in children in India.Linezolid Dose That Maximizes Sterilizing Effect While Minimizing Toxicity and Resistance Emergence for Tuberculosis.A programme to create short-course chemotherapy for pulmonary Mycobacterium avium disease based on pharmacokinetics/pharmacodynamics and mathematical forecasting.A 'shock and awe' thioridazine and moxifloxacin combination-based regimen for pulmonary Mycobacterium avium-intracellulare complex disease.
P2860
Q30275728-FD5EB3A7-2A1A-4B76-BDE4-4EF1B92EFD39Q37339276-999ED031-A393-4717-AEFB-D56B76EE2BECQ37339283-B8353E47-207D-46AF-8F7D-02FC28716E0AQ37339287-5554B5C5-B7A2-412E-88C6-398A567A05EFQ37339294-EAD5374A-8143-40EC-A646-C4C228BB00B3Q38676708-C1A5BB91-CF8E-42D8-901A-85B257994ED1Q40067743-2D1069FB-C62A-4DD8-8407-86AE775FFC04Q40184248-6572111C-6528-4985-916D-7BC394DE9A81Q41996871-52A519C3-1F82-4CCB-95A2-438B86AE4F6FQ41996877-EED3523C-2891-41B1-AFFA-8E26E8F25378
P2860
Optimal Clinical Doses of Faropenem, Linezolid, and Moxifloxacin in Children With Disseminated Tuberculosis: Goldilocks.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Optimal Clinical Doses of Faro ...... ated Tuberculosis: Goldilocks.
@en
Optimal Clinical Doses of Faro ...... ated Tuberculosis: Goldilocks.
@nl
type
label
Optimal Clinical Doses of Faro ...... ated Tuberculosis: Goldilocks.
@en
Optimal Clinical Doses of Faro ...... ated Tuberculosis: Goldilocks.
@nl
prefLabel
Optimal Clinical Doses of Faro ...... ated Tuberculosis: Goldilocks.
@en
Optimal Clinical Doses of Faro ...... ated Tuberculosis: Goldilocks.
@nl
P2093
P2860
P50
P356
P1476
Optimal Clinical Doses of Faro ...... ated Tuberculosis: Goldilocks.
@en
P2093
Devyani Deshpande
Eric Nuermberger
Jotam Pasipanodya
P2860
P304
P356
10.1093/CID/CIW483
P407
P433
P577
2016-11-01T00:00:00Z